IS Nature’s Sunshine Products, Inc. (Nasdaq: NATR), a leading manufacturer of high-quality herbal and nutritional supplements, has reported its Q2 2025 financial results. The company achieved a 4% increase in net sales to $114.8 million, compared to $110.6 million for the same period last year.
CEO Terrence Moorehead stated:
“We delivered another strong quarter with net sales of $115 million and adjusted EBITDA of $11 million, up 4% and 8%, respectively, year-over-year.”
Net Income: Increased to $5.3 million (up from $1.3 million in Q2 2024)
Adjusted EBITDA: Rose 8% to $11.3 million
Gross Profit Margin: Increased to 71.7%
SG&A Expenses: Increased to $43.7 million, reflecting investments in digital marketing
Operating Income: Decreased to $4.3 million
Cash Flow: $6.9 million provided by operating activities
Asia led the growth with $52.7 million in net sales (up 5.4%), followed by North America at $34.9 million (up 4.2%). Other regions, including Europe and Latin America, also saw growth despite market challenges.
Asia: $52.7 million (+5.4%)
Europe: $21.7 million (+0.6%)
North America: $34.9 million (+4.2%)
Latin America & Other: $5.4 million (-0.6%)
In his commentary, Terrence Moorehead highlighted the strength of the company’s strategic initiatives, especially in Japan and Central Europe. The company also continued to see strong performance in its digital business and auto-ship programs, aligning with its long-term global growth strategy.
Gross profit margins increased due to cost-saving measures, offset by unfavorable currency exchange impacts. Meanwhile, volume incentives as a percentage of net sales decreased from 31.4% to 29.9%, primarily due to promotional timing and market mix changes.
If Nature’s Sunshine remains in a solid financial position with $81.3 million in cash and zero debt. The company repurchased 1,011,000 shares for a total of $12.4 million and declared a quarterly cash dividend of $0.05 per share.
Get more information.
There are no reviews yet. Be the first one to write one.
